Is there evidence for the evidence-based guidelines for cardiovascular disease prevention in women?
Roberts
Barbara H
BH
The Women's Cardiac Center at The Miriam Hospital, Providence, RI 02906, USA. bhroberts@lifespan.org
Thompson
Paul D
PD
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D008078:Cholesterol, LDL / Q000097:blood; D002986:Clinical Trials as Topic; D002995:Clofibric Acid / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D009525:Niacin / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D011322:Primary Prevention; D012307:Risk Factors; D016387:Women's Health
D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D000960:Hypolipidemic Agents; D009525:Niacin; D002995:Clofibric Acid